Kiniksa Pharmaceuticals International (KNSA) Accumulated Depreciation & Amortization: 2021-2025
Historic Accumulated Depreciation & Amortization for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to $7.8 million.
- Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization fell 3.54% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.6 million, marking a year-over-year decrease of 0.88%. This contributed to the annual value of $8.2 million for FY2024, which is 5.24% up from last year.
- According to the latest figures from Q3 2025, Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization is $7.8 million, which was up 0.53% from $7.8 million recorded in Q2 2025.
- In the past 5 years, Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization registered a high of $8.2 million during Q4 2024, and its lowest value of $5.0 million during Q1 2021.
- Over the past 3 years, Kiniksa Pharmaceuticals International's median Accumulated Depreciation & Amortization value was $7.8 million (recorded in 2023), while the average stood at $7.8 million.
- Per our database at Business Quant, Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization climbed by 24.98% in 2022 and then decreased by 3.54% in 2025.
- Quarterly analysis of 5 years shows Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization stood at $5.9 million in 2021, then rose by 15.96% to $6.9 million in 2022, then rose by 13.50% to $7.8 million in 2023, then climbed by 5.24% to $8.2 million in 2024, then dropped by 3.54% to $7.8 million in 2025.
- Its Accumulated Depreciation & Amortization was $7.8 million in Q3 2025, compared to $7.8 million in Q2 2025 and $7.8 million in Q1 2025.